Literature DB >> 21149781

15-year cumulative incidence and associated risk factors for retinopathy in nondiabetic persons.

Ronald Klein1, Chelsea E Myers, Kristine E Lee, Barbara E K Klein.   

Abstract

OBJECTIVE: To investigate the relationship of systemic factors to the 15-year cumulative incidence of retinopathy in nondiabetic persons in the Beaver Dam Eye Study.
METHODS: Included were 4699 persons, 43 to 86 years of age at baseline examination in 1988-1990 and with follow-up in 1993-1995 and/or 1998-2000 and/or 2003-2005. Stereoscopic color fundus photographs were graded to determine the presence of retinopathy. The main outcome measure was cumulative incidence of retinopathy accounting for competing risk of death or diabetes mellitus.
RESULTS: The 15-year cumulative incidence of retinopathy in the nondiabetic cohort was 14.2%. In multivariate analyses, older age (hazard ratio [HR] per age group, 1.13; 95% confidence interval [CI], 1.01-1.27), higher systolic blood pressure (HR per 10 mm Hg, 1.15; 95% CI, 1.07-1.20), presence of chronic kidney disease (HR, 1.51; 95% CI, 1.12-2.00), and wider retinal arteriolar diameter (HR per 10 μm, 1.17; 95% CI, 1.10-1.26) at baseline were associated with the incidence of retinopathy. In a separate model, the 15-year incidence of retinopathy was higher in those with uncontrolled hypertension compared with those who did not have hypertension (HR, 2.07; 95% CI, 1.51-2.83). There were no associations of body mass index, lipid levels, glycosylated hemoglobin level, smoking status, markers of inflammation, endothelial dysfunction and oxidative stress, and hematologic factors with retinopathy incidence.
CONCLUSIONS: These data show 2 modifiable factors, uncontrolled hypertension and chronic kidney disease, are related to an increased incidence of retinopathy in nondiabetic persons and show that control of blood pressure is associated with a lower risk of incident retinopathy compared with uncontrolled blood pressure.

Entities:  

Mesh:

Year:  2010        PMID: 21149781      PMCID: PMC3058844          DOI: 10.1001/archophthalmol.2010.298

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  49 in total

1.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 3.  Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy.

Authors:  E M Kohner; V Patel; S M Rassam
Journal:  Diabetes       Date:  1995-06       Impact factor: 9.461

4.  Retinopathy in older persons without diabetes and its relationship to hypertension.

Authors:  T Yu; P Mitchell; G Berry; W Li; J J Wang
Journal:  Arch Ophthalmol       Date:  1998-01

5.  A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study.

Authors:  T Nakayama; C Date; T Yokoyama; N Yoshiike; M Yamaguchi; H Tanaka
Journal:  Stroke       Date:  1997-01       Impact factor: 7.914

6.  Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study.

Authors:  Ronald Klein; Barbara E K Klein; Michael D Knudtson; Tien Y Wong; Michael Y Tsai
Journal:  Arch Ophthalmol       Date:  2006-01

7.  Changes in visual acuity in a population over a 10-year period : The Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; K E Lee; K J Cruickshanks; R J Chappell
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

8.  Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; F Javier Nieto; Lori L Boland; David J Couper; Thomas H Mosley; Barbara E K Klein; Larry D Hubbard; Moyses Szklo
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

9.  The Beaver Dam Eye Study: visual acuity.

Authors:  R Klein; B E Klein; K L Linton; D L De Mets
Journal:  Ophthalmology       Date:  1991-08       Impact factor: 12.079

10.  Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study.

Authors:  T Y Wong; L D Hubbard; R Klein; E K Marino; R Kronmal; A R Sharrett; D S Siscovick; G Burke; J M Tielsch
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

View more
  13 in total

1.  Serum Phosphate and Retinal Microvascular Changes: The Multi-Ethnic Study of Atherosclerosis and the Beaver Dam Eye Study.

Authors:  Rupal Mehta; Alexander Hodakowski; Xuan Cai; Kris E Lee; Bryan R Kestenbaum; Ian H de Boer; Amani Fawzi; Tien Yin Wong; Joachim Ix; Barbara Klein; Ronald Klein; Tamara Isakova
Journal:  Ophthalmic Epidemiol       Date:  2017-04-12       Impact factor: 1.648

2.  Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet.

Authors:  Islam N Mohamed; Sherif S Hafez; Arwa Fairaq; Adviye Ergul; John D Imig; Azza B El-Remessy
Journal:  Diabetologia       Date:  2013-11-08       Impact factor: 10.122

Review 3.  Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit.

Authors:  Islam N Mohamed; Tauheed Ishrat; Susan C Fagan; Azza B El-Remessy
Journal:  Antioxid Redox Signal       Date:  2014-11-11       Impact factor: 8.401

4.  Retinopathy and CKD as predictors of all-cause and cardiovascular mortality: National Health and Nutrition Examination Survey (NHANES) 1988-1994.

Authors:  Ana C Ricardo; Juan E Grunwald; Sharmila Parvathaneni; Sean Goodin; Alice Ching; James P Lash
Journal:  Am J Kidney Dis       Date:  2014-03-19       Impact factor: 8.860

5.  Impact of long-term measures of glucose and blood pressure on the retinal microvasculature.

Authors:  Christy L Avery; Anna Kucharska-Newton; Keri L Monda; A Richey Sharrett; Thomas H Mosley; Barbara E Klein; Mary Frances Cotch; Tien Y Wong; Ronald Klein
Journal:  Atherosclerosis       Date:  2012-10-12       Impact factor: 5.162

6.  Association of Retinopathy and Insulin Resistance: NHANES 2005-2008.

Authors:  Yicheng K Bao; Yan Yan; Bradley Wilson; Mae O Gordon; Clay F Semenkovich; Rithwick Rajagopal
Journal:  Curr Eye Res       Date:  2019-08-28       Impact factor: 2.424

Review 7.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

8.  Diabetes exacerbates retinal oxidative stress, inflammation, and microvascular degeneration in spontaneously hypertensive rats.

Authors:  Islam N Mohamed; Sahar A Soliman; Ahmed Alhusban; Suraporn Matragoon; Bindu A Pillai; Ahmed A Elmarkaby; Azza B El-Remessy
Journal:  Mol Vis       Date:  2012-06-02       Impact factor: 2.367

Review 9.  Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia.

Authors:  Osinakachukwu Mbata; Nada Fawzy Abo El-Magd; Azza Bahram El-Remessy
Journal:  World J Diabetes       Date:  2017-07-15

10.  Genome-wide association study of retinopathy in individuals without diabetes.

Authors:  Richard A Jensen; Xueling Sim; Xiaohui Li; Mary Frances Cotch; M Kamran Ikram; Elizabeth G Holliday; Gudny Eiriksdottir; Tamara B Harris; Fridbert Jonasson; Barbara E K Klein; Lenore J Launer; Albert Vernon Smith; Eric Boerwinkle; Ning Cheung; Alex W Hewitt; Gerald Liew; Paul Mitchell; Jie Jin Wang; John Attia; Rodney Scott; Nicole L Glazer; Thomas Lumley; Barbara McKnight; Bruce M Psaty; Kent Taylor; Albert Hofman; Paulus T V M de Jong; Fernando Rivadeneira; Andre G Uitterlinden; Wan-Ting Tay; Yik Ying Teo; Mark Seielstad; Jianjun Liu; Ching-Yu Cheng; Seang-Mei Saw; Tin Aung; Santhi K Ganesh; Christopher J O'Donnell; Mike A Nalls; Kerri L Wiggins; Jane Z Kuo; Cornelia M van Duijn; Vilmundur Gudnason; Ronald Klein; David S Siscovick; Jerome I Rotter; E Shong Tai; Johannes Vingerling; Tien Y Wong
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.